Oligosaccharyltransferase Inhibition Reduces Receptor Tyrosine Kinase Activation and Enhances Glioma RadiosensitivityCLINICAL CANCER RESEARCHIF10.22019-01-1530OAAI
Oligosaccharyltransferase Inhibition Overcomes Therapeutic Resistance to EGFR Tyrosine Kinase InhibitorsCANCER RESEARCHIF16.62018-09-0454OAAI
Biodegradable PEG-poly(ω-pentadecalactone-co-p-dioxanone) nanoparticles for enhanced and sustained drug delivery to treat brain tumorsBIOMATERIALSIF12.92018-09-0149OAAI